Picture of Grape King Bio logo

1707 Grape King Bio Cashflow Statement

0.000.00%
tw flag iconLast trade - 00:00
Consumer DefensivesConservativeMid CapSuper Stock

Annual cashflow statement for Grape King Bio, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line2,4152,6882,6612,6732,298
Depreciation
Amortisation
Non-Cash Items-5.19-7.96-81-84.5-75.6
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-295-139-520-1,226-599
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities2,5422,9902,5191,8762,180
Capital Expenditures-278-502-601-648-464
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-184172-53.3-14.2-143
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-462-330-655-662-606
Financing Cash Flow Items-565-585-637-640-652
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-1,369-1,629-1,709-1,717-1,745
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash7081,038146-476-178